vs
Side-by-side financial comparison of LIVEPERSON INC (LPSN) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
LIVEPERSON INC is the larger business by last-quarter revenue ($59.3M vs $39.6M, roughly 1.5× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -77.8%, a 113.6% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -19.0%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-12.0M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -16.6%).
LivePerson is a global technology company that develops conversational commerce and AI software.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LPSN vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $59.3M | $39.6M |
| Net Profit | $-46.1M | $14.2M |
| Gross Margin | 73.2% | 73.1% |
| Operating Margin | -68.7% | 32.5% |
| Net Margin | -77.8% | 35.9% |
| Revenue YoY | -19.0% | -10.9% |
| Net Profit YoY | 58.9% | 117.2% |
| EPS (diluted) | $-9.22 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.3M | $39.6M | ||
| Q3 25 | $60.2M | $43.4M | ||
| Q2 25 | $59.6M | $43.4M | ||
| Q1 25 | $64.7M | $47.3M | ||
| Q4 24 | $73.2M | $44.4M | ||
| Q3 24 | $74.2M | $53.1M | ||
| Q2 24 | $79.9M | $53.1M | ||
| Q1 24 | $85.1M | $54.8M |
| Q4 25 | $-46.1M | $14.2M | ||
| Q3 25 | $8.7M | $12.8M | ||
| Q2 25 | $-15.7M | $2.5M | ||
| Q1 25 | $-14.1M | $21.5M | ||
| Q4 24 | $-112.1M | $6.5M | ||
| Q3 24 | $-28.3M | $2.8M | ||
| Q2 24 | $41.8M | $18.5M | ||
| Q1 24 | $-35.6M | $18.8M |
| Q4 25 | 73.2% | 73.1% | ||
| Q3 25 | 71.4% | 70.6% | ||
| Q2 25 | 69.7% | 69.2% | ||
| Q1 25 | 71.8% | 79.7% | ||
| Q4 24 | 77.4% | 76.3% | ||
| Q3 24 | 73.1% | 81.5% | ||
| Q2 24 | 79.4% | 74.2% | ||
| Q1 24 | 71.3% | 72.1% |
| Q4 25 | -68.7% | 32.5% | ||
| Q3 25 | -24.2% | 36.6% | ||
| Q2 25 | -10.8% | 33.6% | ||
| Q1 25 | -26.2% | 51.1% | ||
| Q4 24 | -138.0% | 10.6% | ||
| Q3 24 | -21.6% | 26.1% | ||
| Q2 24 | -37.3% | 51.4% | ||
| Q1 24 | -42.7% | 44.6% |
| Q4 25 | -77.8% | 35.9% | ||
| Q3 25 | 14.5% | 29.6% | ||
| Q2 25 | -26.4% | 5.7% | ||
| Q1 25 | -21.8% | 45.4% | ||
| Q4 24 | -153.2% | 14.7% | ||
| Q3 24 | -38.1% | 5.3% | ||
| Q2 24 | 52.3% | 34.8% | ||
| Q1 24 | -41.8% | 34.2% |
| Q4 25 | $-9.22 | $0.15 | ||
| Q3 25 | $-2.76 | $0.12 | ||
| Q2 25 | $-0.17 | $0.02 | ||
| Q1 25 | $-0.24 | $0.21 | ||
| Q4 24 | $-17.23 | $0.05 | ||
| Q3 24 | $-4.74 | $0.03 | ||
| Q2 24 | $-0.33 | $0.20 | ||
| Q1 24 | $-0.40 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.0M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $-44.5M | $248.3M |
| Total Assets | $454.7M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.0M | $164.1M | ||
| Q3 25 | $106.7M | $127.4M | ||
| Q2 25 | $162.0M | $152.7M | ||
| Q1 25 | $176.3M | $132.1M | ||
| Q4 24 | $183.2M | $125.0M | ||
| Q3 24 | $142.1M | $137.4M | ||
| Q2 24 | $146.0M | — | ||
| Q1 24 | $127.1M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | $512.1M | — |
| Q4 25 | $-44.5M | $248.3M | ||
| Q3 25 | $-22.1M | $248.0M | ||
| Q2 25 | $-82.4M | $244.6M | ||
| Q1 25 | $-74.9M | $226.4M | ||
| Q4 24 | $-67.3M | $195.1M | ||
| Q3 24 | $45.9M | $205.0M | ||
| Q2 24 | $66.6M | $8.8M | ||
| Q1 24 | $19.2M | $9.0M |
| Q4 25 | $454.7M | $380.4M | ||
| Q3 25 | $511.4M | $321.4M | ||
| Q2 25 | $604.2M | $315.3M | ||
| Q1 25 | $596.2M | $284.6M | ||
| Q4 24 | $607.8M | $266.1M | ||
| Q3 24 | $692.0M | $296.5M | ||
| Q2 24 | $703.8M | $19.5M | ||
| Q1 24 | $724.7M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | 26.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.7M | $52.0M |
| Free Cash FlowOCF − Capex | $-12.0M | $51.2M |
| FCF MarginFCF / Revenue | -20.2% | 129.3% |
| Capex IntensityCapex / Revenue | 3.9% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-42.5M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.7M | $52.0M | ||
| Q3 25 | $-6.0M | $-20.9M | ||
| Q2 25 | $-11.7M | $-8.3M | ||
| Q1 25 | $-3.1M | $1.9M | ||
| Q4 24 | $-3.1M | $-7.3M | ||
| Q3 24 | $4.8M | $5.0M | ||
| Q2 24 | $-17.9M | $19.2M | ||
| Q1 24 | $1.1M | $3.7M |
| Q4 25 | $-12.0M | $51.2M | ||
| Q3 25 | $-8.9M | $-20.9M | ||
| Q2 25 | $-14.8M | $-8.6M | ||
| Q1 25 | $-6.9M | $1.7M | ||
| Q4 24 | $-6.8M | $-7.9M | ||
| Q3 24 | $-230.0K | $4.6M | ||
| Q2 24 | $-22.9M | $18.3M | ||
| Q1 24 | $-10.4M | $3.0M |
| Q4 25 | -20.2% | 129.3% | ||
| Q3 25 | -14.8% | -48.3% | ||
| Q2 25 | -24.9% | -19.9% | ||
| Q1 25 | -10.6% | 3.5% | ||
| Q4 24 | -9.2% | -17.8% | ||
| Q3 24 | -0.3% | 8.7% | ||
| Q2 24 | -28.7% | 34.5% | ||
| Q1 24 | -12.2% | 5.4% |
| Q4 25 | 3.9% | 2.0% | ||
| Q3 25 | 4.8% | 0.1% | ||
| Q2 25 | 5.3% | 0.7% | ||
| Q1 25 | 5.8% | 0.5% | ||
| Q4 24 | 5.0% | 1.3% | ||
| Q3 24 | 6.8% | 0.8% | ||
| Q2 24 | 6.2% | 1.6% | ||
| Q1 24 | 13.5% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | -0.69× | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | -0.43× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
